Browse resources

Disease: Haemophilus influenzae type b (Hib)

Total results with these characteristics: 93

Page 2 of 4  
‹ prev.
1
2
3
4
next ›

Haemophilus influenzae type b (Hib)

This supplement to the Journal of Pediatrics features 13 original research articles on Hib. Several of the articles present new data on the impact of Hib vaccines in developing countries, including Bangladesh, The Gambia, Mongolia, and Mozambique. …

Author: Hajjeh R, Mulholland K, Santosham M, eds.

Published: 2013

Haemophilus influenzae type b (Hib) Vaccination Position Paper – July 2013

This article, published in the Weekly Epidemiological Record, summarizes the World Health Organization's recommendations on the inclusion of Haemophilus influenzae type b (Hib) vaccines in all national immunization programs. Vaccination remains the …

Author: World Health Organization

Published: 2013

Hexavalent IPV-Based Combination Vaccines for Public-Sector Markets of Low-Resource Countries

This article, published in Human Vaccines & Immunotherapeutics, evaluates potential hexavalent vaccine candidates containing inactivated polio vaccine (IPV) that could provide reliable, low-cost, and continuous immunization to sustain polio …

Author: Mahmood K, Pelkowski S, Atherly D, Sitrin R, Donnelly JJ

Published: 2013

Hib Vaccination

This page on the CDC website provides an overview of Hib disease and links and information on the Hib vaccine. The web page also has sections containing information especially geared for health professionals and the media.

Author: US Centers for Disease Control and Prevention

Published: 2008

Immunization

This site offers information on vaccine and immunization programs at the American Academy of Pediatrics and includes video and text resources for parents. Resources include frequently asked questions for families, immunization information for …

Author: American Academy of Pediatrics

Immunization of Newborns with Bacterial Conjugate Vaccines

This article, published in Vaccine, discusses the use of bacterial conjugate vaccines in human newborns. Vaccines against Streptococcus pneumoniae, Haemophilus influenzae type B, and Neisseria meningiditis are covered. ABSTRACT ONLY: (Learn how …

Author: van den Biggelaar AH, Pomat WS

Published: 2013

Immunize Canada

This partnership of nongovernmental, professional, health, consumer, government, and private-sector organizations aims to promote the understanding and use of vaccines recommended by Canada's National Advisory Committee on Immunization. Its goal is …

Author: Immunize Canada

Immunizing Children Against Haemophilus influenzae type b

Part of the "Training Resource Series," this training manual for vaccinators can be adapted for specific national programs. In addition to key technical content—including sections on using monovalent, quadrivalent, or pentavalent Hib vaccine …

Author: PATH

Published: 2006

The Immunological Basis for Immunization Series

This web page provides links to individual disease/vaccine-specific modules that are intended to give immunization managers and vaccination professionals a brief and easy-to-understand overview of the scientific basis of vaccination, as well as the …

Author: World Health Organization

The Immunological Basis for Immunization Series, Module 9: Haemophilus influenzae type b

The main purpose of this document--part of the Immunological Basis for Immunization series--is to give vaccination professionals (e.g., EPI managers) a brief and easy-to-understand overview of the scientific basis of vaccination regarding …

Author: World Health Organization

Published: 2007

The Impact of Protein-Conjugate Polysaccharide Vaccines: An Endgame for Meningitis?

The impact of conjugate polysaccharide vaccines on disease is largely due to their effectiveness against asymptomatic carriage of bacteria. This reduces transmission, resulting in herd immunity; however, the effect on carriage can result in the …

Author: Maiden MCJ

Published: 2013

The Impact of Routine Infant Immunization With Haemophilus influenzae type b Conjugate Vaccine in Malawi, a Country With High Human Immunodeficiency Virus Prevalence

Malawi has extreme poverty and high HIV prevalence. Following Haemophilus influenzae type b (Hib) conjugate vaccine introduction during 2002, this study evaluated vaccine impact by reviewing hospital surveillance data for acute bacterial …

Author: Daza P, Banda R, Misoya K, et al.

Published: 2006

Indian Academy of Pediatrics Committee on Immunisation

This website from the Indian Academy of Pediatrics provides up-to-date information on vaccination for the general public and heath care professionals. It provides a range of resources including information about the latest recommendations by …

Author: Indian Academy of Pediatrics Committee on Immunisation

Introducing New Vaccines Into Developing Countries: Obstacles, Opportunities, and Complexities

This commentary, published in Nature Medicine, reviews current trends that may affect whether the most promising of the 350 vaccine candidates under development will eventually be used in programs for the poor in developing countries. It also …

Author: Clemens J, Jodar L

Published: 2005

Introduction of Haemophilus influenzae type b (Hib) as Pentavalent (DPT-HepB-Hib) Vaccine in Two States of India

The National Technical Advisory Group on Immunization in India recommended the introduction of Haemophilus influenzae type b (Hib) vaccine in their Universal Immunization Program (UIP) in 2008. From December 2011, Hib vaccine in combination with …

Author: Gupta SK, Sosler S, Lahariya C

Published: 2012

Introduction of Haemophilus influenzae type b Vaccine into Immunization Programmes

WHO recommends that Hib vaccine now be included in routine infant immunization programmes for all children, as appropriate to national capacities and priorities. This manual provides managers with the information they need to implement a national …

Author: World Health Organization

Published: 2000

Introduction of Hib Vaccine Into National Immunization Programmes: A Descriptive Analysis of Global Trends

This article, published in Vaccine, provides a descriptive analysis of the main characteristics of countries that have included Hib vaccine in their national immunization programs before 2006. It highlights the importance of regularly analyzing the …

Author: Rossi IA, Zuber PL, Dumolard L, Walker DG, Watt J

Published: 2007

Landscape Analysis: Trends in Vaccine Availability and Novel Vaccine Delivery Technologies: 2008–2025

This landscape analysis identifies trends in the availability of vaccines and novel vaccine delivery technologies that are and will be of relevance to low- and middle-income countries from the present through 2025.

Author: PATH, World Health Organization

Published: 2008

Measuring Impact of Streptococcus pneumoniae and Haemophilus influenzae type b Conjugate Vaccination

This manual describes approaches to measuring pneumococcal and Haemophilus influenzae type b conjugate vaccine impact on disease incidence and provides a framework for determining the best methodology in a specific country setting. It details a …

Author: World Health Organization

Published: 2012

Meningococcal Conjugate Vaccines

This article, published in Expert Opinion on Pharmacotherapy, reviews the conjugate meningococcal vaccines currently available and under development and their potential for disease prevention. The article also includes a discussion of the successful …

Author: Zimmer SM, Stephens DS

Published: 2004

More About Haemophilus influenzae type b (Hib)

This web page from the Vaccine Resource Library provides links to information about PATH's work on Haemophilus influenzae type b (Hib), general information about the disease, and a snapshot of the current Hib vaccine landscape.

Author: PATH

Published: 2012

Nasopharyngeal Carriage and Antibiotic Resistance of Haemophilus influenzae in Healthy Children

This study, published in Epidemiology and Infection, examines the isolation rate and antibiotic resistance of Haemophilus influenzae from the nasopharynx of young children.

Author: Howard A, et al.

Published: 1988

National Center for Immunization and Respiratory Diseases (NCIRD)

The mission of the National Center for Immunization and Respiratory Diseases (NCIRD) is the prevention of disease, disability, and death through immunization and by control of respiratory and related diseases. This web page contains additional …

Author: US Centers for Disease Control and Prevention

Optimising the Use of Conjugate Vaccines to Prevent Disease Caused by Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae

This article, published in Vaccine, reviews the state of the current evidence on conjugate vaccines and identifies important areas for further study, in order to inform the debate regarding the best use of these vaccines, which not only prevent …

Author: Trotter CL, McVernon J, Ramsay ME, et al.

Published: 2008

Outcome of Meningitis Caused by Streptococcus Pneumoniae and Haemophilus influenzae type b in Children in the Gambia

Published in the journal Tropical Medicine and International Health, the purpose of this study was to assess the importance of disabilities following pneumococcal and Hib meningitis in The Gambia. 257 children aged 0-12 years hospitalized between …

Author: Goetghebuer T, et al.

Published: 2000

Page 2 of 4  
‹ prev.
1
2
3
4
next ›